Can antigenic drift of SARS-CoV-2 spike protein jeopardize current vaccine development?

An effective vaccine against COVID-19 is widely considered the most promising exit strategy from the gravest pandemic in over a century. There were over 70 candidates employing diverse technology platforms as reported by the WHO in April 2020, most targeting the spike (S) protein/subunits of SARS-CoV-21